The success of the National Center relies on its ability to collaborate with a wide audience. Tasked with several multidisciplinary projects, reaching interest from those with diverse backgrounds and expertise mutually benefits the development of gene therapy and drugs based on RNA technology. Building collaborative relationships with other research centers, companies, institutes, and new business venture, demonstrates the National Center’s commitment to bringing break through treatments to market. The National Center is eager to hear from you.